MRNA
MRNA
NASDAQ · Biotechnology

Moderna Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$59.35
-4.62 (-7.22%)
As of Jun 22, 9:41 PM ET ·
Analyst Consensus
Hold
30
Analysts
Very High
Coverage
Buy 4 13%
Hold 19 63%
Sell 7 23%
Price Target
Analyst Price Target +151.8% upside
Low Target $89.97
Average Target $149.45
High Target $212.09
Current Price $59.35
Current
$59.35
Target
$149.45
$89.97 $149.45 avg $212.09
Scenario Analysis
Bear Case
$89.97
51.6%
Low target
Base Case
$149.45
+151.8%
Avg target
Bull Case
$212.09
+257.4%
High target
Risk/Reward
5.0x
Highly favorable
Price in Context
52-Week High
$67.74
-12.4% from high
52-Week Low
$22.28
+166.4% from low
50-Day SMA
$37.98
+56.3% vs SMA
200-Day SMA
$29.64
+100.2% vs SMA
RSI (14)
57.2
Neutral
Target vs 52W High
$149.45
+120.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%